Albion Financial Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.95M | Sell |
63,236
-3,966
| -6% | -$320K | 0.29% | 64 |
|
|
2026
Q1 | $5.82M | Sell |
67,202
-407
| -0.6% | -$39K | 0.38% | 56 |
|
|
2025
Q4 | $6.49M | Sell |
67,609
-3,913
| -5% | -$380K | 0.4% | 56 |
|
|
2025
Q3 | $6.81M | Buy |
71,522
+1,545
| +2% | +$142K | 0.41% | 57 |
|
|
2025
Q2 | $6.1M | Buy |
69,977
+913
| +1% | +$77.4K | 0.4% | 59 |
|
|
2025
Q1 | $6.21M | Buy |
69,064
+49,206
| +248% | +$4.4M | 0.44% | 55 |
|
|
2024
Q4 | $1.59M | Sell |
19,858
-790
| -4% | -$68.4K | 0.11% | 91 |
|
|
2024
Q3 | $1.86M | Buy |
20,648
+9
| +0% | +$757 | 0.13% | 84 |
|
|
2024
Q2 | $1.62M | Buy |
20,639
+81
| +0.4% | +$6.64K | 0.12% | 85 |
|
|
2024
Q1 | $1.79M | Buy |
20,558
+1,887
| +10% | +$161K | 0.14% | 81 |
|
|
2023
Q4 | $1.54M | Sell |
18,671
-826
| -4% | -$63K | 0.13% | 85 |
|
|
2023
Q3 | $1.53M | Buy |
19,497
+2,279
| +13% | +$191K | 0.14% | 81 |
|
|
2023
Q2 | $1.52M | Sell |
17,218
-2,327
| -12% | -$200K | 0.13% | 84 |
|
|
2023
Q1 | $1.58M | Buy |
19,545
+789
| +4% | +$64.3K | 0.14% | 83 |
|
|
2022
Q4 | $1.46M | Sell |
18,756
-2,090
| -10% | -$169K | 0.14% | 87 |
|
|
2022
Q3 | $1.68M | Sell |
20,846
-854
| -4% | -$76.7K | 0.17% | 80 |
|
|
2022
Q2 | $1.95M | Buy |
21,700
+2,325
| +12% | +$236K | 0.19% | 80 |
|
|
2022
Q1 | $2.15M | Buy |
19,375
+1,921
| +11% | +$203K | 0.18% | 80 |
|
|
2021
Q4 | $1.81M | Sell |
17,454
-2,444
| -12% | -$283K | 0.14% | 90 |
|
|
2021
Q3 | $2.49M | Buy |
19,898
+134
| +0.7% | +$17.3K | 0.22% | 77 |
|
|
2021
Q2 | $2.45M | Buy |
+19,764
| New | +$2.48M | 0.21% | 78 |
|
|
2020
Q4 | $1.97M | Buy |
16,811
+1,582
| +10% | +$174K | 0.19% | 78 |
|
|
2020
Q3 | $1.58M | Buy |
15,229
+121
| +0.8% | +$12.2K | 0.17% | 81 |
|
|
2020
Q2 | $1.39M | Buy |
15,108
+340
| +2% | +$32.6K | 0.16% | 80 |
|
|
2020
Q1 | $1.33M | Buy |
14,768
+918
| +7% | +$97.7K | 0.19% | 72 |
|
|
2019
Q4 | $1.57M | Sell |
13,850
-492
| -3% | -$54K | 0.19% | 80 |
|
|
2019
Q3 | $1.56M | Buy |
14,342
+75
| +0.5% | +$7.83K | 0.2% | 75 |
|
|
2019
Q2 | $1.39M | Hold |
14,267
| – | – | 0.18% | 84 |
|
|
2019
Q1 | $1.3M | Hold |
14,267
| – | – | 0.18% | 84 |
|
|
2018
Q4 | $1.3M | Buy |
14,267
+58
| +0.4% | +$5.42K | 0.2% | 82 |
|
|
2018
Q3 | $1.4M | Buy |
14,209
+55
| +0.4% | +$5.08K | 0.19% | 81 |
|
|
2018
Q2 | $1.21M | Buy |
14,154
+373
| +3% | +$31.2K | 0.17% | 84 |
|
|
2018
Q1 | $1.11M | Hold |
13,781
| – | – | 0.17% | 86 |
|
|
2017
Q4 | $1.11M | Hold |
13,781
| – | – | 0.17% | 85 |
|
|
2017
Q3 | $1.07M | Hold |
13,781
| – | – | 0.16% | 86 |
|
|
2017
Q2 | $1.22M | Hold |
13,781
| – | – | 0.2% | 75 |
|
|
2017
Q1 | $1.11M | Sell |
13,781
-100
| -0.7% | -$7.81K | 0.17% | 79 |
|
|
2016
Q4 | $989K | Sell |
13,881
-3,174
| -19% | -$249K | 0.16% | 87 |
|
|
2016
Q3 | $1.47M | Buy |
17,055
+115
| +0.7% | +$10K | 0.25% | 69 |
|
|
2016
Q2 | $1.47M | Sell |
16,940
-240
| -1% | -$19.4K | 0.26% | 54 |
|
|
2016
Q1 | $1.29M | Hold |
17,180
| – | – | 0.22% | 62 |
|
|
2015
Q4 | $1.32M | Sell |
17,180
-3,112
| -15% | -$234K | 0.23% | 56 |
|
|
2015
Q3 | $1.36M | Sell |
20,292
-1,320
| -6% | -$97.2K | 0.25% | 55 |
|
|
2015
Q2 | $1.6M | Hold |
21,612
| – | – | 0.27% | 48 |
|
|
2015
Q1 | $1.69M | Buy |
21,612
+81
| +0.4% | +$6.14K | 0.29% | 44 |
|
|
2014
Q4 | $1.55M | Hold |
21,531
| – | – | 0.27% | 49 |
|
|
2014
Q3 | $1.33M | Sell |
21,531
-339
| -2% | -$21.6K | 0.24% | 59 |
|
|
2014
Q2 | $1.39M | Hold |
21,870
| – | – | 0.24% | 62 |
|
|
2014
Q1 | $1.35M | Hold |
21,870
| – | – | 0.25% | 59 |
|
|
2013
Q4 | $1.25M | Sell |
21,870
-100
| -0.5% | -$5.67K | 0.24% | 61 |
|
|
2013
Q3 | $1.17M | Hold |
21,970
| – | – | 0.25% | 59 |
|
|
2013
Q2 | $1.13M | Buy |
+21,970
| New | +$1.09M | 0.25% | 58 |
|
Other funds holding MDT
Albion Financial Group's MDT Position: Q2 2026 in Review
Albion Financial Group reduced its Medtronic (MDT) stake by 5.9% in Q2 2026, selling an estimated $320K and leaving 63,236 shares worth $4.95M. The position accounts for 0.29% of the portfolio, ranked #64.
Albion Financial Group first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.81M in Q3 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Albion Financial Group held 63,236 shares of Medtronic worth $4.95M as of Q2 2026.
- Albion Financial Group sold 3,966 Medtronic shares in Q2 2026, an estimated $320K.
- Medtronic made up 0.29% of Albion Financial Group's portfolio in Q2 2026, its #64 holding.
- Albion Financial Group first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Albion Financial Group's Medtronic position peaked at $6.81M in Q3 2025.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.